ProfileGDS4132 / 220490_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 53% 65% 37% 35% 48% 49% 52% 58% 32% 36% 32% 40% 30% 28% 38% 45% 35% 31% 35% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101143.60553
GSM201543Muscle PCOS pioglitazone 121177.89265
GSM201544Muscle PCOS pioglitazone 16196.277537
GSM201545Muscle PCOS pioglitazone 20197.557635
GSM201829Muscle PCOS pioglitazone 231137.03548
GSM201830Muscle PCOS pioglitazon 251136.43349
GSM201831Muscle PCOS pioglitazone 271142.40452
GSM201832Muscle PCOS pioglitazone 31156.45358
GSM201833Muscle PCOS pioglitazone 4175.484632
GSM201834Muscle PCOS pioglitazone 8190.159836
GSM201835Muscle PCOS after pioglitazone 10266.084732
GSM201836Muscle PCOS after pioglitazone 12291.225740
GSM201837Muscle PCOS after pioglitazone 16260.363630
GSM201838Muscle PCOS after pioglitazone 20258.904128
GSM201839Muscle PCOS after pioglitazone 23290.321238
GSM201840Muscle PCOS after pioglitazone 252115.05145
GSM201841Muscle PCOS after pioglitazone 27274.951435
GSM201842Muscle PCOS after pioglitazone 3262.137931
GSM201843Muscle PCOS after pioglitazone 4284.9535
GSM201844Muscle PCOS after pioglitazone 8296.302239